Abstract : Alzheimer s disease AD is one of the most common causes of dementia, characterized by the accumulation of amyloid-A peptide deposits in the brain. Within an aging society, elderly patients with preoperative dementia, or those who are affected by postoperative cognitive impairment, are a major health problem. Although inhalation anesthetics induce accumulation of A protein and progression of AD, propofol, a short-acting intravenous anesthetic, has gained increasing attention for its neuroprotective effects following cerebral ischemia. However, the protective action of propofol against A -induced neuronal damage remains unclear. Therefore, the aim of this study was to elucidate the mechanisms underlying the protective effect of propofol against A -induced neurotoxicity. Neural damage was induced in human neuroblastoma cells SH-SY5Y using 2.5 µM A 1-42 . Cells were pretreated with propofol 1 µM for 1 h, followed by further treatment with propofol for 20 h in combination with A . In A 1-42 -induced neural damage, caspase-3 activation was increased, as was phosphorylation of p38 mitogen-activated protein kinase MAPK and tau. Moreover, cell viability and the phosphorylation of Akt, cAMP response element-binding protein, and Bcl-2 decreased significantly with A treatment. However, these responses were reversed by pretreatment with propofol and p38MAPK inhibitor. The A 1-42 -induced increase in reactive oxygen species generation was inhibited by propofol pretreatment, but remained unchanged following pretreatment with the p38MAPK inhibitor. Furthermore, A 1-42 -treated cells exhibited a significant increase in cytosolic Ca Our results indicate that the mechanism underlying the protective effect of propofol against A -induced neurotoxicity is a decrease in Ca 2 i , which subsequently suppresses oxidative stress, along with p38MAPK and tau phosphorylation. Thus, these findings suggest that propofol, at clinically relevant concentrations, is likely to be safe in elderly patients and in those with risk factors for AD.
Introduction
Dementia is a major medical problem worldwide, markedly reducing quality of life. Indeed, dementia is a disease accompanied by a variety of debilitating symptoms, including learning disabilities, memory loss, and poor judgment. Because dementia is a tremendous burden to a patient s family and caregivers, it can also be considered a serious problem at the societal level. Due to increasing life expectancies, there is a larger population of the elderly worldwide, with increasing numbers of dementia patients. Alzheimer s disease AD is the most common type of dementia and is the most common neurodegenerative disease among the elderly. AD causes many severe cognitive disorders involving memory, learning, and orientation impairment. AD is also characterized by the accumulation of amyloid-A peptide deposits and intraneuronal neurofibrillary tangles NFTs in the brain 1 .
In an aging society, the number of elderly patients requiring general anesthesia is increasing. However, surgery and anesthesia in elderly patients have often been reported to cause cognitive disorders, including AD, as well as to reduce postoperative cognitive function, which is a serious health problem 2 .
Inhaled anesthetic agents, such as halothane and isoflurane, have been reported to trigger A aggregation, which promotes AD progression and the formation of amyloid plaques 3 . However, long-term treatment with the anesthetic propofol 2,6-diisopropylphenol in aged mice has been reported to reduce A production 4 . Furthermore, propofol treatment in humans 5 , aged wildtype mice, or AD transgenic mice is shown to result in improved cognitive function 6 . Propofol is a widely used short-acting intravenous anesthetic agent that actives -aminobutyric acid GABA A receptors and inhibits N-methyl-D-aspartate NMDA receptors 7 . In addition to maintaining sedation as an anesthetic agent, propofol has antioxidative 8 , antiemetic, antianxiety, and neuroprotective effects 9 . Furthermore, it has been reported that the cytoprotective action of propofol involves selective inhibition of Ca 2 influx through L-type calcium channels in smooth muscle cells 10 and the inhibition of Ca 2 release from intracellular stores into the cytoplasm 11 .
One of the common factors underlying AD pathogenesis is the dysregulation of neuronal intracellular Ca overload, the generation of reactive oxygen species ROS , and increased activity of caspase and mitochondrial proteins, such as cytochrome c, that stimulate apoptosis, and have been shown to be associated with cell death and neurodegeneration 12 .
The mitogen-activated protein kinase MAPK signaling pathway is known to be involved in the etiology of various neurodegenerative diseases, such as AD, Parkinson s disease, and amyotrophic lateral sclerosis 13 . Phosphorylation of p38MAPK, an MAPK that responds to stress stimuli, has been observed postmortem in the brains of early stage AD patients Braak staging IV-V 14 . Furthermore, p38MAPK activation has been reported to play various roles in AD pathology, such as mitochondrial dysfunction, apoptosis, tau phosphorylation, and synaptic dysfunction 15 . Therefore, inhibitors of p38MAPK may be a promising strategy for AD therapy.
Indeed, propofol has been shown to reduce H 2 O 2 -induced neurotoxicity by inhibiting the p38MAPK signaling pathway in PC12 cells 16 .
However, the association of p38MAPK with the protective mechanism of action of propofol against A -induced neurotoxicity has not been investigated. Therefore, the aims of the present study were to elucidate the mechanism underlying the protective effects of propofol against A -induced neurotoxicity in SH-SY5Y cells and to evaluate propofol as a possible alternative anesthetic for elderly or early AD patients.
Materials and methods

Drugs and reagents
A 1-42 human was purchased from Peptide Institute Osaka, Japan . Monomeric A 1-42 was incubated for 24 h at 37 C to allow self-aggregation and oligomerization before treatment. Propofol 2,6-diisopropylphenol , all-trans-retinoic acid ATRA , and Dulbecco s modi ed Eagle s medium DMEM / Ham s F-12 were purchased from Wako Osaka, Japan . Fetal bovine serum FBS and inhibitors of p38MAPK SB202190 , c-Jun N-terminal kinase JNK ; SP600125 , and mitogen-activated protein kinase kinase MEK 1 / 2 PD98059 were purchased from Sigma-Aldrich St. Louis, MO, USA . Penicillin G sodium, streptomycin sulfate, and amphotericin B were obtained from Life Technologies Camarillo, CA, USA . All other chemicals used were the purest grade available commercially.
Cell culture and drug treatment
SH-SY5Y cells human neuroblastoma, EC-94030304 were obtained from The European Collection of Authenticated Cell Cultures London, UK . SH-SY5Y cells were cultured in DMEM / Ham s F-12 containing 10 FBS and antibiotic-antimycotic solution and maintained under a humidified atmosphere of 5 CO 2 and 95 air at 37 C. SH-SY5Y cells are comparable to neurons in their morphological and neurochemical properties, and have been widely used to evaluate neuronal injury or death in neurodegenerative diseases, cerebral ischemia-reperfusion, and epilepsy 17 . To evaluate the effects of A , SH-SY5Y cells were first differentiated with ATRA. Differentiated cells were subsequently cultured with or without control A for 20 h at 37 C. In the present study, differentiated SH-SY5Y cells were pretreated with propofol 1, 2, or 5 µM for 1 h before cotreatment with 2.5 µM A for a further 20 h. In some experiments, differentiated cells were incubated with MAPK inhibitors 10 µM for 15 min prior to treatment with propofol. All treatments were performed under sterile conditions.
Cell viability assay
Cell viability was measured based on the formation of blue formazan, which is metabolized from colorless 3-4,5-dimethyl-2 thiazoyl -2,5-diphenyl-2H-tetrazolium bromide MTT by mitochondrial dehydrogenases that are active only in live cells. A preliminary experiment was conducted in which SH-SY5Y cells were treated with A 1, 2.5, 5, or 10 µM , and 2.5 µM A was found to be a suitable concentration for inducing cytotoxicity in SH-SY5Y cells Fig. 1A .
To study the protective effects of propofol against A -induced cytotoxicity, SH-SY5Y cells were pretreated with 1 µM propofol for 1 h, followed by treatment with A propofol for 20 h. After incubation, the supernatant was removed and the formation of the formazan was measured at 540 nm using Cell Proliferation Kit I Roche Diagnostics, Mannheim, Germany and a microplate reader Spectra Max i3 ; Molecular Devices, San Jose, CA, USA .
Staining with Annexin V and Hoechst 33342
SH-SY5Y cells cultured in six-well plates were treated with 2.5 µM A and 1 µM propofol for 20 h, after which they were stained using the DNA dye Hoechst 33342 Wako to visualize nuclear morphology. Stained cells were then washed in phosphate-buffered saline PBS , and the specific binding of Annexin V-Cy3 Annexin V-Cy3 Apoptosis Detection Kit ; Medical & Biological Laboratories, Nagoya, Japan was investigated by incubating the cells for 5 min at room temperature in binding buffer containing Annexin V. The Annexin V-Cy3 Apoptosis Detection Kit detects the distribution of phosphatidylserine in the outer monolayer of cell membranes, which is present in the early stages of apoptosis, using fluorescence emitted from specific Cy3-labeled Annexin V. After 20 h incubation with A , cells were stained according to the manufacturer s instructions and examined under a fluorescence microscope DIAPHOT TMD 300 ; Nikon, Tokyo, Japan . When SH-SY5Y cells were viewed under the fluorescence microscope, staining of apoptotic cells in the early stages was observed.
Caspase-3 activity
Caspase-3 activity was determined fluorometrically using appropriate synthetic peptide substrates provided by Kamiya Biomedical Company Seattle, WA, USA . SH-SY5Y cells were incubated with or without 1 µM propofol for 1 h, followed by treatment with 2.5 µM A propofol for 20 h. After incubation, cells were rinsed with cold PBS and resuspended in chilled cell lysis buffer Cell Signaling Technology, Danvers, MA, USA , incubated for 10 min on ice, and then centrifuged at 10,000 g for 3 min at 4 C. The supernatant was then added to reaction buffer containing 10 µM dithiothreitol DTT ; Medical & Biological Laboratories, Aichi, Japan and respective speci c peptide substrates, and incubated at 37 C for 60 min. The substrate for caspase-3 Kamiya Biochemical Company was Asp-Glu-Val-Asp-7-amino-4-tri uoromethylcoumarin DEVD-AFC . AFC released by the enzymatic reaction was measured spectrophotometrically at an excitation wavelength of 405 nm and an emission wavelength of 505 nm using a Spectra Max i3 Molecular Devices .
MAPK phosphorylation
The role of MAPK in A -induced neurotoxicity in SH-SY5Y cells was examined by investigating MAPK phosphorylation. The phosphorylation of p38MAPK, JNK, and ERK1 / 2 was determined using cell-based p38MAPK or anti-ERK1 / 2 primary antibody , respectively. Then, the cells were washed with washing buffer in the assay kit again, after which horseradish peroxidase HRP -conjugated anti-mouse IgG secondary antibody was added. The cells were washed with washing buffer in the assay kit again and 3, 3 , 5, 5 -tetramethylbenzidine TMB substrate solution was added, resulting in the development of color in proportion to the amount of protein. When the reaction was stopped by the addition of the stop solution in the assay kit, the color changed from blue to yellow, and the intensity of the color was measured at 450 nm.
Detection of Akt and tau phosphorylation
SH-SY5Y cells were incubated with or without 1 µM propofol for 1 h, followed by treatment with A propofol for 20 h. Akt protein kinase B is a serine / threonine-specific protein kinase that plays an important role in many cellular processes, such as apoptosis, cell proliferation, and tau phosphorylation 18 . To evaluate Akt phosphorylation, SH-SY5Y cells were extracted with a cell lysis buffer Cell Signaling Technology , incubated for 10 min on ice, and then centrifuged at 10,000 g for 3 min at 4 C. Akt phosphorylation was then determined in cell lysate samples using the p-Akt pSer 473 / pan-Akt ELISA kit Sigma-Aldrich .
After incubation for 1 h, the phosphorylation of tau in the cell was determined using a Human Tau pS396 Assay ELISA kit Invitrogen, Carlsbad, CA, USA .
Detection of cAMP response element-binding protein phosphorylation and Bcl-2 assay
cAMP response element-binding protein CREB , which is activated by the phosphorylation of residue Ser
133
, is one of the best characterized transcription factors ; CREB phosphorylation is an event induced by various extracellular signals 19 . In the present study, SH-SY5Y cells were lysed in a cytoplasmic extraction buffer in the assay kit. Phosphorylation of CREB was determined using the CREB Total InstantOne ELISA kit and the CREB Phospho InstantOne ELISA kit Affymetrix, Santa Clara, CA, USA . Protein concentrations in the samples were then determined using the DC Protein Assay Bio-Rad Laboratories . After 20 h exposure to A , with or without 1 h pretreatment with propofol or a p38MAPK inhibitor, SH-SY5Y cells were extracted with the cell lysis buffer provided in the Human Bcl-2 Platinum ELISA kit eBioscience, Vienna, Austria for the quantitative determination of Bcl-2 in SH-SY5Y cell lysates.
Detection of ROS
To study the effect of A treatment on H 2 O 2 production, we used the chloromethyl derivative of 2 , 7 -dichlorodihydrofluorescein diacetate CM-H 2 DCFDA , a useful indicator for ROS detection. SH-SY5Y cells were seeded in 96-well plates at a density of 1 10 5 cells / ml and incubated as described above in the Cell Culture section. A Spectra Max i3 Molecular Devices was used to determine the fluorescence intensity at excitation and emission wavelengths of 488 and 525 nm, respectively.
Measurement of Ca 2 i by Meta Xpress Image Acquisition
After pretreatment with 1 µM propofol, 1 µM memantine, or 10 µM nicardipine, SH-SY5Y cells were exposed with 2.5 µM A . Ca 
Statistical analysis
Each measurement was repeated three times. Results are expressed as the mean SEM. The effects of various treatments were compared with untreated control cells using one-way analysis of variance ANOVA and Dunnett s post hoc test, with p 0.05 considered statistically significant.
Results
Effects of propofol on cell viability and Annexin V and Hoechst 33342 staining in A -stimulated SH-SY5Y cells
First, we examined the effect of A on cell viability Fig. 1A 
Effects of propofol on caspase-3 activity
Caspases play critical roles in the apoptosis of SH-SY5Y cells ; therefore, caspase-3 activity was measured in the present study using a synthetic fluorometric substrate Fig. 2 . After incubation of SH-SY5Y cells with A 2.5, 5, or 10 µM for 20 h, caspase-3 activity increased significantly compared with that in untreated control cells. Incubation of cells with propofol 1, 5, or 10 µM or 10 µM p38MAPK inhibitor SB202190 had no significant effect on caspase-3 activity. However, pretreatment of cells with propofol 1 µM or 10 µM p38MAPK inhibitor SB202190 significantly suppressed the increase in caspase-3 activity seen in cells treated with 2.5 µM A alone Fig. 2 .
Effects of propofol on MAPK phosphorylation in A -stimulated SH-SY5Y cells
Phosphorylation of p38MAPK, JNK, and ERK was compared among untreated and 2.5 µM A -treated SH-SY5Y cells, with or without 1 µM propofol pretreatment Fig. 3A . Phosphorylation of the three MAPKs increased signi cantly in A -treated SH-SY5Y cells compared with untreated cells. Propofol pretreatment decreased the A -induced increase in the phosphorylation of p38MAPK and JNK Fig. 3A , B , but had no significant effect on ERK1 / 2 phosphorylation Fig. 3C . On the basis of these results, it is reasonable to speculate that p38MAPK is activated in A -treated SH-SY5Y cells, whereas ERK does not seem to play a major role. Thus, subsequent studies were performed on p38MAPK. in A -stimulated SH-SY5Y cells. p38MAPK, JNK, and ERK1 / 2 phosphorylation was examined using ELISA kits, as described in the Materials and Methods. SH-SY5Y cells were pretreated or not for 1 h with 1 µM propofol, followed by exposure to 2.5 µM A for 30 min. The effects of p38MAPK, JNK, and ERK1 / 2 inhibitors SB202190, SP600125, and PD98059, respectively were also examined. Data are the mean SEM. p 0.05 compared with control cells ; p 0.05 compared with 2.5 µM A -treated cells. Propofol Protects against A Neurotoxicity
Effects of propofol on Akt and tau phosphorylation in A -stimulated SH-SY5Y cells
To study the effects of propofol on the phosphorylation of Akt in A -induced neurotoxicity, we first examined how propofol affected levels of p-Akt.
As shown in Fig. 4A , the p-Akt / total-Akt ratio was decreased in A -treated compared with untreated SH-SY5Y cells ; however, the A -induced reduction in this ratio was recovered by pretreatment of cells with 1 µM propofol. Furthermore, pretreatment of cells with 10 µM p38MAPK inhibitor SB202190 resulted in a significant increase in Akt phosphorylation compared with that in the A propofol-treated group Fig. 4A . It has been demonstrated that NFTs are formed by hyperphosphorylated tau protein, which is the pathological hallmark of AD 19 . In the present study, tau phosphorylation was increased significantly in A -treated compared with untreated cells Fig. 4B . However, the A -induced increase in p-tau was recovered by pretreatment with 1 µM propofol or 10 µM p38MAPK inhibitor SB202190 .
Effects of propofol on CREB phosphorylation and Bcl-2 levels in A -stimulated SH-SY5Y cells
CREB phosphorylation and levels of the anti-apoptotic protein Bcl-2 were investigated in SH-SY5Y cells.
To study the effects of propofol on CREB phosphorylation in A -induced neurotoxicity, we first examined how propofol affected total CREB and p-CREB levels. As shown in Fig. 5A , CREB phosphorylation was increased significantly in propofol-treated compared with untreated SH-SY5Y cells. Exposure of SH-SY5Y cells to A for 20 h led to a decrease in p-CREB / total-CREB ratio. However, the A -induced reduction in this ratio was recovered by pretreatment with 1 µM propofol. CREB phosphorylation in cells pretreated with the p38MAPK inhibitor SB202190 did not differ significantly from that in the propofol A -treated cells. Bcl-2 levels were investigated in untreated or 2.5 µM A -treated SH-SY5Y cells, with or without pretreatment with 1 µM propofol or 10 µM p38MAPK inhibitor SB202190 ; Fig. 5B . Bcl-2 levels were significantly decreased in A -treated cells, but this reduction in Bcl-2 was significantly suppressed by pretreatment with 1 µM propofol or 10 µM p38MAPK inhibitor SB202190 . Pretreatment with the p38MAPK inhibitor SB202190 significantly increased Bcl-2 levels compared with levels in the A propofol-treated group Fig. 5B .
Effects of propofol on ROS production in A -stimulated SH-SY5Y cells
CM-H 2 DCFDA, a ROS-sensitive dye, was used in the present study as an indicator of ROS formation to investigate of the effects of A treatment on hydrogen peroxide production. As shown in Fig. 6 , ROS production increased dose dependently in SH-SY5Y cells treated with A 
Discussion
In the present study we demonstrated that propofol, a short-acting intravenous anesthetic, has a protective effect against A -induced neurotoxicity in SH-SY5Y cells.
Preclinical, animal, and in vitro cell culture studies have reported that anesthetics induce neuronal apoptosis, caspase activation, neurodegeneration, accumulation and oligomerization of A , and, ultimately, cognitive decline. Recent studies have shown that 25 of patients over 65 years of age develop delirium after surgery and short-and long-term postoperative cognitive impairment following cardiac and non-cardiac operations 20 . Exposure to anesthesia during surgery can cause the onset or progression of AD in patients with mild cognitive impairment MCI or AD. However, in the present study propofol treatment reduced A -induced neurocytotoxicity in SH-SY5Y cells Figs. 1, 2 . These results suggest that the use of propofol in patients with MCI or dementia has the potential to prevent the progression of AD by inhibiting neuron death due to A .
In A -exposed SH-SY5Y cells, Bcl-2 and Akt phosphorylation was decreased, ROS production was increased, and p38MAPK and tau phosphorylation was increased Figs. 2, 3B, 4B, 6 . Pretreatment of SH-SY5Y cells with a p38MAPK inhibitor SB202190 significantly inhibited these effects of A , with the exception of ROS generation, which did not change significantly ; thus, p38MAPK does not appear to regulate ROS generation Fig. 6 . These results suggest that A -induced p38MAPK activation occurs downstream of ROS generation. Recent AD research using cellular and animal models has shown that p38MAPK regulates various AD-related phenomena, such as tau phosphorylation, neurotoxicity, neuroinflammation, and synaptic dysfunction 15 . Furthermore, examination of brains of AD patients postmortem suggests high p38MAPK expression in regions of the brain associated with learning and memory. Thus, p38MAPK is likely an important factor of higher brain function. NFTs in an AD brain were reported to have formed aggregates of hyperphosphorylated tau protein via p38MAPK 13 .
A leads to decreased Akt-dependent Ser 9 phosphorylation of glycogen synthase kinase GSK 3 , promoting GSK3 activity and resulting in increased tau phosphorylation. Furthermore, A reduced Bcl-2 and activated caspase-3 to promote apoptosis, and reduced the viability of SH-SY5Y cells Fig. 8 . However, pretreatment with propofol inhibited A -induced neurotoxicity. Propofol has demonstrated cytoprotective effects by inhibiting excessive ROS generation in both in vitro and in vivo ischemia-reperfusion models 21 , and suppresses H 2 O 2 -induced p38MAPK activation in neurons and human umbilical vein endothelial cells HUVEC 16 . In the present study, propofol significantly inhibited the A -induced increase in ROS production, caspase-3 activity, and p38MAPK and tau phosphorylation, as well as the A -induced decrease in Bcl-2 and Akt phosphorylation. Propofol has been shown to protect hippocampal neurons in ischemic brain injury and against H 2 O 2 -induced oxidative stress 22 via the Akt signaling pathway. Because pretreatment with the p38MAPK inhibitor also increased Bcl-2 and Akt phosphorylation, inhibition of p38MAPK activity by propofol may have increased Akt phosphorylation and Bcl-2 levels and reduced tau phosphorylation and caspase-3 activation to inhibit neuronal damage. Although we used propofol at low concentrations in the present study, several previous studies have indicated that treatment with propofol at high concentrations promotes apoptosis. For example, a study in which macrophages were exposed to 140 µM propofol for 24 h reported that the treatment promoted apoptosis 23 . Other studies have shown that treatment of human glioblastoma cells with 300-500 µM propofol increases Ca 2 i in a dose-dependent manner as part of the induction of apoptosis 24 .
Typically, 1.0-2.5 mg / kg propofol is administered to patients as an intravenous bolus injection to induce general anesthesia. In using a target control infusion TCI pump, the target plasma propofol concentrations are maintained between 2.0 and 5.0 µg / ml. However, propofol binds to plasma proteins mean 97 -98 bound 25 , with 50 bound to erythrocytes and 48 bound to serum proteins, almost exclusively to human serum albumin. At a total concentration of 0.5-32 µg / ml, the free propofol fraction in the blood is 1.2 -1.7 . Based on these data, we used 1 µM propofol in a FBS-free culture medium in the present study. A promotes Ca 2 influx through the plasma membrane into neurons, and this is widely known as the primary mechanism of neurodegeneration. A induces a sustained increase in Ca 2 i by activating NMDA receptors on the cell membrane, which is believed to be one of the major causes of neurodegeneration in AD 26 . Direct injection of A 1-40 into the hippocampus also induces neural loss in the CA1 region, whereas treatment with memantine, an NMDA receptor antagonist, reduces neurodegeneration 27 . In the present study, memantine pretreatment also suppressed the A -induced increase in Ca 2 i Fig. 7 . Therefore, the results of the present study support the notion that the NMDA receptor plays a role in A -induced neurotoxicity.
A also causes Ca 2 influx into neurons via VDCC. In the central nervous system there are two main types of L-type calcium channels, Cav1.2 and Cav1.3. In a recent study, expression of Cav1.2 and Cav1.3 was reportedly increased by A 25-35 in rat hippocampal and human kidney cells HEK293 28 . In the present study, nicardipine pretreatment suppressed A 1-42 -induced increases in Ca In conclusion, the present study demonstrated that propofol inhibits A -induced increases in Ca 2 i and p38MAPK activation in SH-SY5Y cells, thus protecting against neurodegeneration by suppressing A -induced upregulation of tau phosphorylation and downregulation of Bcl-2 and CREB Fig. 8 . Thus, propofol is believed to be a beneficial anesthetic that works by protecting against oxidative stress, mitochondrial dysfunction, and apoptosis, and may serve as an anesthetic agent to prevent neuronal damage.
Therefore, it is suggested that the use of propofol at clinically relevant concentrations appears safe for elderly patients and for patients with risk factors for AD.
